Canada is working toward producing the Novavax COVID-19 vaccine.
Prime Minister Justin Trudeau announced a new agreement with Novavax, which includes construction of a production facility in Montreal.
The work is expected to be done by the end of the year.
“Pending Health Canada approval, tens of millions of Novavax COVID-19 doses will be made right here at home,” Trudeau says.
He says Precision NanoSystems is also on track to produce made-in-Canada vaccines. It will receive up to $25.1 million in federal funding to build a vaccine and treatment production facility.
The federal government is also giving up to $14 million to Edesa Biotech for COVID-19 treatments.
